Why a little-known drug discount program is so controversial

Drugmakers, hospitals, clinics and policymakers have argued for years over a program known as 340B.

Related Keywords

United States ,American ,Dan Gorenstein ,Sayeh Nikpay ,Bryan Levi ,Tradeoffs Research Editor ,A Supreme Court ,Supreme Court ,Affordable Care Act , ,